InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-10.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by HUME DANIEL, Director. Director active across 1 company, notably TG Therapeutics, INC.. In total, 6 reports have been published. Activity tracked since 18 June 2021. The latest transaction was filed on 17 March 2025 (Don). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
62,459 shares0Common StockSEC:0001437749-25-008284:0
22,250 shares0Common StockSEC:0001437749-24-020850:0
20,000 shares0Common StockSEC:0001104659-23-105400:0
43,732 shares0Common StockSEC:0001104659-22-082022:0
20,000 shares0COMMON STOCKSEC:0001104659-21-084259
20,000 shares0COMMON STOCKSEC:0001104659-21-084259:0
6 of 6 declarations
About HUME DANIEL
Daniel Hume is a Director at TG THERAPEUTICS, INC. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the pharmaceutical sector and understanding of market challenges allow him to provide valuable insights during board discussions.
